Effect of Melasma on quality of life in patient with melasma using DLQI (dermatology life quality index)


  • Manisha Singh Basukala Kist medical college
  • Ayush Jha Kist medical college
  • Rima Shrestha Kist medical college
  • Sita Poudel Kist medical college


Introduction:Melasma is an acquired pigmentary disorder that has a negative impact on various domains of patient’s quality of life. Measurement of quality of life can help in enhancing patients care and outcomes. The study was done to assess DLQI (Dermatology Life Quality Index) in Melasma patients and its correlation with clinical severity.

Methods:A cross-sectional hospital based study was conducted and fifty clinically diagnosed cases of Melasma were included after informed consent. Clinical and epidemiological data was obtained as per structured proforma. Severity of Melasma was measured as per MASI (Melasma Area and Severity Index) score. Dermatology Life Quality Index was used to assess the quality of life. Statistical analyses were performed as per standard statistical protocols.

Results:The mean age of the patients included in our study was 31.14 (±7.12) years. A female preponderance (n=43; 86%) was observed in our study. A family history of Melasma was obtained from sixteen patients (29.63%). Centrofacial type of Melasma was the most frequently encountered pattern in our study subjects. The average MASI and DLQI score of our patients was 4.44 (± 1.91) and 5.24 (±4.97), respectively. No significant correlation was observed in between MASI and DLQI scores (p=.228).

Conclusion:The present study showed that Melasma causes a moderate reduction in quality of life.




How to Cite

Basukala, M. S., Jha, A., Shrestha, R., & Poudel , S. (2022). Effect of Melasma on quality of life in patient with melasma using DLQI (dermatology life quality index). Journal of KIST Medical College, 4(8), 6–10. Retrieved from https://journal.kistmcth.edu.np/index.php/JKISTMC/article/view/207